Presentation slides and video from the 2017 Advances in Cancer Immunotherapy™ - Philadelphia, PA held on August 4, 2017 are available here.Program Organizers
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these programs will facilitate understanding of:
Meeting: Advances in Cancer Immunotherapy™- Philadelphia, PA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Basic Principles of Cancer Immunotherapy; Presenter: David H. Henry, MD - University of Pennsylvania; Date: August 4th, 201700:28:06
Meeting: Advances in Cancer Immunotherapy™- Philadelphia, PA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session II: Overcoming Barriers to Incorporating Immunotherapy Into Community Practice; Presentation: Coverage and Reimbursement Challenges and Strategies; Presenter: Matthew Zibelman, MD - Fox Chase Cancer Center; Date: August 4th, 201700:18:16
Meeting: Advances in Cancer Immunotherapy™- Philadelphia, PA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session II: Overcoming Barriers to Incorporating Immunotherapy Into Community Practice; Presentation: Effective Practices for Incorporating Immunotherapy into Hospital Operations; Presenter: Matthew Zibelman, MD - Fox Chase Cancer Center; Date: August 4th, 201700:20:03
Meeting: Advances in Cancer Immunotherapy™- Philadelphia, PA; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Identification and Management of Immune-Related Adverse Events in the Emergency Setting; Presenter: Maura Sammon, MD, FAAEM - Temple University School of Medicine; Date: August 4th, 201700:32:30
Meeting: Advances in Cancer Immunotherapy™- Philadelphia, PA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Genitourinary Cancers; Presenter: Vivek Narayan, MD MSCE - University of Pennsylvania; Date: August 4th, 201700:19:22
Meeting: Advances in Cancer Immunotherapy™- Philadelphia, PA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Head and Neck Cancers; Presenter: Joshua Bauml, MD - University of Pennsylvania; Date: August 4th, 201700:16:42
Meeting: Advances in Cancer Immunotherapy™- Philadelphia, PA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Hematologic Malignancies; Presenter: Stephen J. Schuster, MD - University of Pennsylvania; Date: August 4th, 201700:20:10
Meeting: Advances in Cancer Immunotherapy™- Philadelphia, PA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Lung Cancer; Presenter: Corey J. Langer, MD - University of Pennsylvania; Date: August 4th, 201700:20:59
Meeting: Advances in Cancer Immunotherapy™- Philadelphia, PA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy: Presentation: Immunotherapy for the Treatment of Melanoma; Presenter: Marlana Orloff, MD - Thomas Jefferson University Hospital; Date: August 4th, 201700:20:51
Meeting: Advances in Cancer Immunotherapy™- Philadelphia, PA; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Management and Mitigation of irAEs for Immunotherapy Prescribers; Presenter: Kathleen Madden, MSN, FNP-BC, AOCNP, APHN - New York University Cancer Institute; Date: August 4th, 201700:22:13
Meeting: Advances in Cancer Immunotherapy™- Philadelphia, PA; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Mechanisms of Immune-Related Adverse Events; Presenter: Justine V. Cohen, DO - Massachusetts General Hospital; Date: August 4th, 201700:18:28
Meeting: Advances in Cancer Immunotherapy™- Philadelphia, PA; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Nursing Perspective on irAEs: Patient Education, Monitoring and Management; Presenter: Ellen Napier, CRNP - University of Pennsylvania; Date: August 4th, 201700:23:00
Meeting: Advances in Cancer Immunotherapy™- Philadelphia, PA; Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice; Session II: Overcoming Barriers to Incorporating Immunotherapy Into Community Practice; Presentation: Take-Home Points from Part A; Date: August 4th, 201700:24:04
Meeting: Advances in Cancer Immunotherapy™- Philadelphia, PA; Part B: Immune-Related Adverse Event (irAE) Management; Presentation: Take-Home Points from Part B; Date: August 4th, 201700:12:45